The Discounted Cash Flow (DCF) valuation of scPharmaceuticals Inc (SCPH) is (26.97) USD. With the latest stock price at 3.97 USD, the upside of scPharmaceuticals Inc based on DCF is -779.2%.
Based on the latest price of 3.97 USD and our DCF valuation, scPharmaceuticals Inc (SCPH) is a sell. selling SCPH stocks now will result in a potential gain of 779.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 9.8% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (154.94) - (15.34) | (26.97) |
| Upside | -4002.7% - -486.3% | -779.2% |